CABERGOLINE

Adverse reactions of Cabergoline are manifested in cases of individual intolerances to the active agent or significant increases of recommended dosages. Excessive dosage leads to a rapid decrease in the concentration of prolactin in the body, which is fraught with reduced appetite, insomnia, dizziness, constipation, nausea, skin rash, labored breathing, depressed mood, peripheral oedema, low blood pressure. Before using Cabergoline, it is necessary to test for the concentration of prolactin in the body.

Cabergoline is often used in sports in the traditional regimen of 0.25 mg of the active agent once every 4 days. When the concentration of prolactin significantly exceeds the normal values, it is used at 0.25 mg once every two days until the level of the peptide hormone is reduced to the normal level, after which the drug is taken in the traditional regimen. In addition to the abovementioned positive properties of Cabergoline, the use of the drug during a steroid cycle eliminates adverse reactions in the form of face swelling and excessive fluid accumulation in muscle tissue.

The drug can be used in sports not only during an anabolic steroid cycle with high progestin activity, but Cabergoline can also enhance the effect of steroid substances and improve the users’ sex life. In this case, 0.5 mg of the active agent is used every 10 days. Cabergoline can be used as an additional drug during post-cycle therapy if a high concentration of prolactin is observed in the body. The optimal dosages are 0.25 mg once every seven days throughout PCT.